{
    "Clinical Trial ID": "NCT00181363",
    "Intervention": [
        "INTERVENTION 1: ",
        "  Prone",
        "Prone position",
        "INTERVENTION 2: ",
        "  Supine",
        "Supine position"
    ],
    "Eligibility": [
        "Inclusion Criteria:",
        "  Patients should have had breast-conserving surgery for breast cancer or DCIS (Ductal Carcinoma in Situ)",
        "  No indication for radiotherapy of regional nodes",
        "  Large, pendulous breasts (bra size D and over)",
        "Exclusion Criteria:",
        "  Regional radiotherapy is indicated",
        "  Unable to lie in prone position"
    ],
    "Results": [
        "Outcome Measurement: ",
        "  Dose Homogeneity 1: PTV",
        "  Quantitatively compare the 3 D dose distribution in the PTV (Planning Target Volume) and normal tissues in prone position versus supine position",
        "  Time frame: 1 day after treatment planning",
        "Results 1: ",
        "  Arm/Group Title: Prone",
        "  Arm/Group Description: Prone position",
        "  Overall Number of Participants Analyzed: 10",
        "  Mean (Standard Deviation)",
        "  Unit of Measure: Gy  Dmin (Gy) PTV: 9.8         (6.7)",
        "  Dmean (Gy) PTV: 48.2         (1.2)",
        "  Dmax (Gy) PTV: 53.6         (0.6)",
        "Results 2: ",
        "  Arm/Group Title: Supine",
        "  Arm/Group Description: Supine position",
        "  Overall Number of Participants Analyzed: 10",
        "  Mean (Standard Deviation)",
        "  Unit of Measure: Gy  Dmin (Gy) PTV: 8.2         (5.6)",
        "  Dmean (Gy) PTV: 49.8         (0.8)",
        "  Dmax (Gy) PTV: 54.8         (1.4)"
    ],
    "Adverse Events": [
        "Adverse Events 1:",
        "  Total: 0/10 (0.00%)",
        "Adverse Events 2:",
        "   "
    ]
}